Related Experiment Video
Updated: Apr 30, 2026

MeRIP-qPCR Assay for Detecting m6A Modification Levels of Specific RNA in Osteosarcoma Cells
Published on: December 30, 2025
microRNA-145 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1
Pengfei Lei1, Jie Xie1, Long Wang1
1Department of Orthopedics, Xiangya Hospital of Central South University, Changsha, Hunan 410008, P.R. China.
Abstract:
Osteosarcoma (OS), a malignant mesenchymal sarcoma, is the most frequent primary bone tumor, with a peak incidence in young children and adolescents. The downregulation of microRNA‑145 (miRNA/miR‑145) has previously been identified to be associated with the aggressiveness and metastasis of OS. However, the detailed regulatory mechanism by which miR‑145 inhibits OS remains largely unknown. The present study demonstrated that miR‑145 was significantly downregulated in OS tissues and KHOS and U2OS cell lines. Rho‑associated protein kinase 1 (ROCK1), a key regulator of actin cytoskeleton reorganization, was identified as a novel target of miR‑145. Ectopic expression of miR‑145 notably suppressed the protein expression of ROCK1 without affecting its mRNA level. Furthermore, the expression of ROCK1 was significantly increased in the OS tissues and in the KHOS and U2OS cells. It was further demonstrated that the overexpression of miR‑145 downregulated KHOS and U2OS cell proliferation and invasion, which was reversed by restoration of ROCK1. To the best of our knowledge, the present study demonstrates for the first time that, as a tumor suppressor, miRNA‑145 inhibits OS cell proliferation and invasion, at least in part by directly targeting ROCK1. These results indicate that miR‑145 may be a potential candidate for the diagnosis and treatment of OS.
Insights
MicroRNA-145 (miR-145) suppresses osteosarcoma (OS) growth and spread by targeting ROCK1. This discovery offers potential new diagnostic and therapeutic strategies for this bone cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Osteosarcoma (OS) is the most common primary bone cancer in children and adolescents.
- Reduced levels of microRNA-145 (miR-145) are linked to OS aggressiveness and metastasis.
- The precise mechanism of miR-145's tumor-suppressive role in OS is not fully understood.
Purpose of the Study:
- To elucidate the regulatory mechanism of miR-145 in osteosarcoma.
- To identify novel molecular targets of miR-145 in OS.
- To investigate the potential of miR-145 as a diagnostic and therapeutic agent for OS.
Main Methods:
- Quantified miR-145 and Rho-associated protein kinase 1 (ROCK1) expression in OS tissues and cell lines.
- Utilized cell culture models (KHOS, U2OS) to study miR-145 and ROCK1 interactions.
- Performed gain-of-function experiments for miR-145 and rescue experiments with ROCK1 restoration.
Main Results:
- miR-145 was significantly downregulated in OS tissues and cell lines.
- ROCK1 was identified as a direct target of miR-145, with miR-145 suppressing ROCK1 protein but not mRNA levels.
- ROCK1 expression was elevated in OS tissues and cells.
- Overexpression of miR-145 inhibited OS cell proliferation and invasion, effects that were reversed by restoring ROCK1.
Conclusions:
- miR-145 functions as a tumor suppressor in osteosarcoma.
- miR-145 inhibits OS cell proliferation and invasion, partly through direct targeting of ROCK1.
- miR-145 represents a potential biomarker and therapeutic target for osteosarcoma.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Experimental RNAi
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation

